Spyre Therapeutics Inc

0
FRA:3920 (USA)  
€ 34.40 (+0.15%) Nov 8
At Loss
P/B:
9.19
Market Cap:
€ 1.89B ($ 2.02B)
Enterprise V:
€ 1.74B ($ 1.87B)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Compare
Compare
Traded in other countries / regions
SYRE.USA3920.Germany
IPO Date
2024-03-08
Description
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.86
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 81.52
9-Day RSI 76.09
14-Day RSI 72.16
6-1 Month Momentum % -21.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.7
Quick Ratio 19.7
Cash Ratio 19.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -165.9

Financials (Next Earnings Date:2025-02-28 Est.)

FRA:3920's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Spyre Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.812
EPS (TTM) (€) -12.262
Beta 0
Volatility % 0
14-Day RSI 72.16
14-Day ATR (€) 0.80736
20-Day SMA (€) 30.235
12-1 Month Momentum % 0
52-Week Range (€) 20.9 - 40.9
Shares Outstanding (Mil) 51.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Spyre Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Spyre Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Spyre Therapeutics Inc Frequently Asked Questions

What is Spyre Therapeutics Inc(FRA:3920)'s stock price today?
The current price of FRA:3920 is €34.40. The 52 week high of FRA:3920 is €40.90 and 52 week low is €20.90.
When is next earnings date of Spyre Therapeutics Inc(FRA:3920)?
The next earnings date of Spyre Therapeutics Inc(FRA:3920) is 2025-02-28 Est..
Does Spyre Therapeutics Inc(FRA:3920) pay dividends? If so, how much?
Spyre Therapeutics Inc(FRA:3920) does not pay dividend.

Press Release

Subject Date
No Press Release